is tirzepatide being taken off the market for compounded GLP-1 drugs remained robust despite the end of semaglutide (Ozempic, Wegovy) and (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with FDA Says Compounded Tirzepatide Must

Quinine iris toxicity

Therapeutic Advances in Reproductive Health , 15 , 1-22

Nonetheless, with the exception of certain viral encephalitis and prion disorders [499], such conditions are not fundamentally enigmatic and are less central to current neurodegeneration-focused drug development efforts compared to diseases like AD or frontotemporal lobar degeneration

These enzymes are up-regulated or down-regulated depending on cellular glutathione concentrations and exert a similar effect on glutathione itself

Thankfully, most GLP-1 shortages have been resolved since early 2025, but a shortage can also drive people to switch from tirzepatide to semaglutide, or semaglutide to tirzepatide